Abstract

Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty‐six patients (14.6%) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4‐yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88%. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95% survival). Three patients were high risk, with two deaths (33% survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.

Original languageEnglish (US)
Pages (from-to)1136-1141
Number of pages6
JournalThe American journal of gastroenterology
Volume85
Issue number9
DOIs
StatePublished - Jan 1 1990

Fingerprint

Sclerosing Cholangitis
Liver Transplantation
Transplantation
Survival
Transplants
Liver Failure
Liver Diseases
Referral and Consultation
Mortality
Liver

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Primary Sclerosing Cholangitis : The Emerging Role for Liver Transplantation. / Langnas, Alan Norman; Grazi, G. L.; Stratta, R. J.; Wood, R. P.; Marujo, W.; Markin, Rodney Smith; Donovan, J.; Burnett, D.; Zetterman, Rowen K; Sorrell, Michael Floyd; Shaw, B. W.

In: The American journal of gastroenterology, Vol. 85, No. 9, 01.01.1990, p. 1136-1141.

Research output: Contribution to journalArticle

Langnas, Alan Norman ; Grazi, G. L. ; Stratta, R. J. ; Wood, R. P. ; Marujo, W. ; Markin, Rodney Smith ; Donovan, J. ; Burnett, D. ; Zetterman, Rowen K ; Sorrell, Michael Floyd ; Shaw, B. W. / Primary Sclerosing Cholangitis : The Emerging Role for Liver Transplantation. In: The American journal of gastroenterology. 1990 ; Vol. 85, No. 9. pp. 1136-1141.
@article{bb343e17444c4829b34e21949d1a691b,
title = "Primary Sclerosing Cholangitis: The Emerging Role for Liver Transplantation",
abstract = "Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty‐six patients (14.6{\%}) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4‐yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88{\%}. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95{\%} survival). Three patients were high risk, with two deaths (33{\%} survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.",
author = "Langnas, {Alan Norman} and Grazi, {G. L.} and Stratta, {R. J.} and Wood, {R. P.} and W. Marujo and Markin, {Rodney Smith} and J. Donovan and D. Burnett and Zetterman, {Rowen K} and Sorrell, {Michael Floyd} and Shaw, {B. W.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1111/j.1572-0241.1990.tb09118.x",
language = "English (US)",
volume = "85",
pages = "1136--1141",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Primary Sclerosing Cholangitis

T2 - The Emerging Role for Liver Transplantation

AU - Langnas, Alan Norman

AU - Grazi, G. L.

AU - Stratta, R. J.

AU - Wood, R. P.

AU - Marujo, W.

AU - Markin, Rodney Smith

AU - Donovan, J.

AU - Burnett, D.

AU - Zetterman, Rowen K

AU - Sorrell, Michael Floyd

AU - Shaw, B. W.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty‐six patients (14.6%) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4‐yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88%. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95% survival). Three patients were high risk, with two deaths (33% survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.

AB - Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty‐six patients (14.6%) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4‐yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88%. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95% survival). Three patients were high risk, with two deaths (33% survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.

UR - http://www.scopus.com/inward/record.url?scp=0025154889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025154889&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.1990.tb09118.x

DO - 10.1111/j.1572-0241.1990.tb09118.x

M3 - Article

VL - 85

SP - 1136

EP - 1141

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -